• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Nektar Therapeutics - Common Stock (NQ:NKTR)

41.44 -2.07 (-4.76%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 570,483
Open 43.51
Bid (Size) 41.27 (100)
Ask (Size) 43.78 (200)
Prev. Close 43.51
Today's Range 41.25 - 43.79
52wk Range 6.480 - 66.92
Shares Outstanding 183,801,441
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nektar Therapeutics - NKTR
January 06, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
Ignore Nektar Therapeutics Stock in 2026 and Load Up on This One Instead ↗
January 05, 2026
There is a key difference between these two biotechs. 
Via The Motley Fool
Topics Bankruptcy

Performance

YTD
-4.6%
-4.6%
1 Month
-27.7%
-27.7%
3 Month
-26.7%
-26.7%
6 Month
+77.4%
+77.4%
1 Year
+132.2%
+132.2%

More News

Read More
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nektar Therapeutics - NKTR
December 30, 2025
From Pomerantz LLP
Via GlobeNewswire
News headline image
Earnings Scheduled For November 6, 2025 ↗
November 06, 2025
Via Benzinga
News headline image
Earnings Scheduled For August 7, 2025 ↗
August 07, 2025
Via Benzinga
News headline image
This Biotech Is Up 194% in a Year but One Investor Took Millions Off the Table ↗
December 28, 2025
Via The Motley Fool
Topics Regulatory Compliance
News headline image
ANI Stock Is Up 49% This Past Year, Revenue Is Surging, and One Fund Still Walked Away ↗
December 28, 2025
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Cidara Therapeutics Is Up Over 100%. Here's What Investors Need to Know. ↗
November 20, 2025
Via The Motley Fool
News headline image
Nektar Therapeutics (NASDAQ:NKTR) Q3 2025 Earnings Top Estimates, Sending Shares Higher ↗
November 06, 2025
Via Chartmill
News headline image
This Stock Is Up By 285% This Year But Could Still Jump By 53%, According to Wall Street ↗
October 13, 2025
Via The Motley Fool
News headline image
Here's Why Nektar Therapeutics Stock Rocketed 90.6% Higher in September ↗
October 05, 2025
Via The Motley Fool
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
October 03, 2025
Via Benzinga
News headline image
These 2 Healthcare Stocks Are Up Over 100% in a Month. Can They Keep Climbing? ↗
September 21, 2025
Via The Motley Fool
News headline image
Why Nektar Therapeutics Stock Zoomed More Than 15% Higher Today ↗
September 18, 2025
Via The Motley Fool
News headline image
Why Is Nektar Therapeutics Stock Trading Lower On Thursday? ↗
September 18, 2025
Via Benzinga
News headline image
Why Nektar Therapeutics Rippled Higher This Week ↗
September 05, 2025
Via The Motley Fool
Topics Intellectual Property
News headline image
What's Going On With Nektar Therapeutics Stock On Thursday? ↗
September 04, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
September 04, 2025
Via Benzinga
News headline image
Shoe Carnival, American Eagle, Ciena, Victoria's Secret And Other Big Stocks Moving Higher On Thursday ↗
September 04, 2025
Via Benzinga
News headline image
Why Nektar Therapeutics Stock Popped 6% on Friday ↗
August 08, 2025
Via The Motley Fool
News headline image
Nektar (NKTR) Q2 Revenue Falls 52% ↗
August 08, 2025
Via The Motley Fool
News headline image
3 Bullish Biotech Stocks With Explosive Growth Trends ↗
July 21, 2025
Via MarketBeat
News headline image
Why Nektar Therapeutics Stock Dived by 3% Today ↗
July 03, 2025
Via The Motley Fool
News headline image
US Stock Futures Slip After Two Days Of Record Advances: 'FOMO Could Add Another 5%-10%...,' Says Expert ↗
July 01, 2025
Via Benzinga
News headline image
MSC Industrial Direct, Constellation Brands And 3 Stocks To Watch Heading Into Tuesday ↗
July 01, 2025
Via Benzinga

Frequently Asked Questions

Is Nektar Therapeutics - Common Stock publicly traded?
Yes, Nektar Therapeutics - Common Stock is publicly traded.
What exchange does Nektar Therapeutics - Common Stock trade on?
Nektar Therapeutics - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Nektar Therapeutics - Common Stock?
The ticker symbol for Nektar Therapeutics - Common Stock is NKTR on the Nasdaq Stock Market
What is the current price of Nektar Therapeutics - Common Stock?
The current price of Nektar Therapeutics - Common Stock is 41.44
When was Nektar Therapeutics - Common Stock last traded?
The last trade of Nektar Therapeutics - Common Stock was at 01/08/26 04:00 PM ET
What is the market capitalization of Nektar Therapeutics - Common Stock?
The market capitalization of Nektar Therapeutics - Common Stock is 7.62B
How many shares of Nektar Therapeutics - Common Stock are outstanding?
Nektar Therapeutics - Common Stock has 8B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap